• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的凝血酶凝血时间及纤维蛋白聚合反应

Thrombin clotting time and fibrin polymerization in liver cirrhosis.

作者信息

Szczepański M, Habior A, Szczepanik A, Soszka A, Grel K

机构信息

Dept. of Biochemistry, Medical Center of Postgraduate Education, Warsaw, Poland.

出版信息

Mater Med Pol. 1994 Jul-Sep;26(3):87-90.

PMID:7603083
Abstract

The thrombin clotting time and the fibrin polymerization test were performed in 64 patients with liver cirrhosis. Each test was made with thrombin diluted with 150 mmol/l sodium chloride and 25 mmol/l calcium chloride. The thrombin-in-NaCl clotting time was found to be prolonged in 39% of cirrhotic patients, whereas fibrin polymerization was defective in 65% of them. Dilution of thrombin with calcium chloride diminished the number of abnormal results of both tests in patients with liver cirrhosis. Among the performed tests most sensitive test proved to be the polymerization of fibrin induced by thrombin diluted with sodium chloride.

摘要

对64例肝硬化患者进行了凝血酶凝血时间和纤维蛋白聚合试验。每项试验均使用用150 mmol/L氯化钠和25 mmol/L氯化钙稀释的凝血酶进行。发现39%的肝硬化患者凝血酶在氯化钠中的凝血时间延长,而65%的患者纤维蛋白聚合存在缺陷。用氯化钙稀释凝血酶可减少肝硬化患者两项试验的异常结果数量。在所进行的试验中,最敏感的试验被证明是用氯化钠稀释的凝血酶诱导的纤维蛋白聚合。

相似文献

1
Thrombin clotting time and fibrin polymerization in liver cirrhosis.肝硬化患者的凝血酶凝血时间及纤维蛋白聚合反应
Mater Med Pol. 1994 Jul-Sep;26(3):87-90.
2
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.简单凝血试验(纤维蛋白原测定和凝血酶凝固时间)在肝癌诊断中的重要性。
J Med. 1984;15(2):149-60.
3
A study of impaired fibrin polymerization in patients with the nephrotic syndrome.一项关于肾病综合征患者纤维蛋白聚合受损的研究。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(1):73-8.
4
Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times.
Thromb Haemost. 1995 Mar;73(3):349-55.
5
Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.肝硬化中的纤维蛋白肽A:反对弥散性血管内凝血对慢性肝病凝血病起主要作用的证据
J Lab Clin Med. 1993 Jan;121(1):83-90.
6
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?肝硬化中的弥散性血管内凝血:事实还是虚构?
Am J Gastroenterol. 1999 Oct;94(10):2977-82. doi: 10.1111/j.1572-0241.1999.01446.x.
7
Thrombin generation in patients with cirrhosis: the role of platelets.肝硬化患者的凝血酶生成:血小板的作用。
Hepatology. 2006 Aug;44(2):440-5. doi: 10.1002/hep.21266.
8
Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.纤维蛋白原巴斯蒂亚(γ318 天冬氨酸→酪氨酸):一种以纤维蛋白聚合缺陷为特征的新型异常纤维蛋白原。
Thromb Haemost. 1999 Dec;82(6):1639-43.
9
Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.纤维蛋白原圣加仑I(γ292位甘氨酸突变为缬氨酸):结构改变导致聚合缺陷和纤维蛋白原溶解的证据
Thromb Haemost. 1999 Feb;81(2):268-74.
10
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.尽管传统凝血试验异常,但肝硬化患者凝血酶生成正常的证据。
Hepatology. 2005 Mar;41(3):553-8. doi: 10.1002/hep.20569.